Blockade by 4,4′‐diisothiocyanatostilbene‐2,2′‐disulphonate (DIDS) of P2X‐purinoceptors in rat vas deferens
Open Access
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (2) , 690-694
- https://doi.org/10.1111/j.1476-5381.1994.tb13131.x
Abstract
The possibility of an antagonist effect of 4,4′‐diisothiocyanatostilbene‐2,2′‐disulphonate (DIDS) at P2X‐purinoceptors was studied in rat vas deferens. DIDS reduced contractions elicited by α,β‐methylene ATP 3 μm, IC50 1.6 μm, but did not change contractions elicited by K+ 35 mm. DIDS 3.2 μm slightly shifted the concentration‐response curve of α,β‐methylene ATP to the right and reduced the maximum. DIDS 10 μm markedly decreased and DIDS 32 μm abolished contractions over the entire range of the α,β‐methylene ATP concentration‐response curve. DIDS 32 μm also abolished contractions elicited by ATP but did not change contractions elicited by noradrenaline. The antagonist effect of DIDS was only slowly reversible. The presence of either suramin 320 μm or α,β‐methylene ATP 10 μm during the exposure to DIDS protected the tissue from the long‐lasting blocking effect of DIDS. 4,4′‐Diisothiocyanatodihydrostilbene‐2,2′‐disulphonate (H2DIDS) was equipotent with DIDS whereas several analogues in which one or both of the isothiocyanate residues were replaced were less effective or without effect against α,β‐methylene ATP. DIDS attenuated the purinergic component of neurogenic contractions elicited by electrical field stimulation, IC50 3.9 μm, but did not change the adrenergic component. It is concluded that DIDS causes a selective, long‐lasting, non‐equilibrium blockade of P2X‐purinoceptors in rat vas deferens. Due to this effect it also selectively blocks the purinergic component of neurogenic contractions.Keywords
This publication has 30 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptorsBritish Journal of Pharmacology, 1993
- Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter releaseNeuroscience, 1993
- Blockade of ATP binding site of P2 purinoceptors in rat parotid acinar cells by isothiocyanate compoundsBiochemical Pharmacology, 1993
- P2 receptor: Subclassification and structure-activity relationshipsDrug Development Research, 1993
- Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferensEuropean Journal of Pharmacology, 1992
- Noradrenaline-ATP co-transmission in the sympathetic nervous systemTrends in Pharmacological Sciences, 1991
- A receptor that is highly specific for extracellular ATP in developing chick skeletal muscle in vitroBritish Journal of Pharmacology, 1991
- P2‐Purinoceptor AntagonistsaAnnals of the New York Academy of Sciences, 1990
- Inhibitory effects of 4,4′-diisothiocyanostilbene-2,2′-disulfonate (DIDS) on the ADP-stimulated aggregation of gel-filtered bovine blood plateletsBiochemical and Biophysical Research Communications, 1983